Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies
Yuan Li1, Janine A Burns1, Carol A Cheney1, Ningyan Zhang1, Salvatore Vitelli1, Fubao Wang1, Andrew Bett2, Michael Chastain2, Laurent P Audoly1, Zhi-Qiang Zhang1,31Department of Biologics Research, 2Department of Vaccine Research, Merck Research Laboratories, West Point, PA, USA; 3Clinical Developme...
Guardado en:
Autores principales: | Yuan Li, Janine A Burns, Carol A Cheney, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/beeff8bff40a4e49a92c0583a2605216 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis AM, et al.
Publicado: (2012) -
Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
por: Cruz E, et al.
Publicado: (2019) -
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
por: Sun S, et al.
Publicado: (2021) -
A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
por: Syed Mohammed Basheeruddin Asdaq, et al.
Publicado: (2021) -
Quantitative <i>N-</i>Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis
por: Bastiaan L. Duivelshof, et al.
Publicado: (2021)